Minutes - Medication WG 2022-06-21

Attendees

• Annemieke Vergauwe
• Bart Decuypere
• Jean-Michel Polfliet
• Jens Penny
• José Costa Teixeira
• Karlien Erauw
• Pablo Christiaens
• Tom Henkens

Excused/Not present

• Anne Nerenhausen
• Bruno Casneuf
• Dieter Sauvillers
• Elhassan Baazizi
• Hanne Vuegen
• Jan Lenie
• Jean-Louis Maggetto
• Katrien Thorré
• Lars Vanreppelen
• Marc Buckens
• Nick Hermans
• Nils Devos
• Richard Francken
• Thomas Van Langendonck
• Tom De Backer
• Walter Bollaert
• Will van Norel

Agenda

• Future of medication scheme

Minutes

• Work on business rules is still ongoing at RIZIV end
• before we said that it has to be part of the implementation guide

• however, can we go and publish the medication scheme ?
• goal is for prescribor applications to start using the medication treatment

• We need some documentation for the migration from Kmehr to FHIR: input is needed
• We have to complexities of contraindications and (drug) allergies & intolerances

• drug allergies & intolerances are related to decision support, therefore might not be needed to include in the medication scheme but offer as additional service
• modelling of contraindications needs still to be determined, which can also be temporarily (f.e. pregnancy, breastfeeding)
• allergy & intolerance will be the way to present this kind of info
• there are 2 types for which distinction need to be made: patient related & drug related
• patient's condition is part of medical history (f.e. epilepsy)

• SAM viewer, there is VNP, CNK etc

• how many tables are there in the database ?
• this is the hierarchy: vmp-group > AMP > AMPP > CNK (old)
• concepts to be uses in MS will have to be defined

• f.e. support substances ?
• Jens will have a look

Agenda items for next meeting

• Current state of profiles on medication view and treatment lines and how it all works at operational level
• Review made changes
• Collect feedback on contraindications
• Identifying business rules

Next meeting July 5 at 11AM